Drug companies aren’t
exactly known for their reputations.
But public opinions about them
have changed in some surprising ways in recent years, especially amidst
recent controversies over the
high and rising prices
of drugs.
A new analysis from the research
consulting firm Reputation Institute evaluated public perceptions of
14 pharmaceutical companies in 7 key areas: 1) products and services, 2)
innovation, 3) workplace, 4) governance, 5) citizenship, 6) leadership, and 7)
financial performance.
The report found that on
average, drug companies continue to be perceived as having a so-so
reputation. In fact, people’s opinion of the
pharmaceutical industry overall has improved since 2015.